Is pelvic lymphadenectomy really necessary in patients with a serum prostate-specific antigen level of <10 ng/ml undergoing radical prostatectomy for prostate cancer?

被引：20
|
作者：
Burkhard, FC [1 ]
Schumacher, M [1 ]
Thalmann, GN [1 ]
Studer, UE [1 ]
机构：
[1] Univ Bern, Dept Urol, Bern, Switzerland
来源：
BJU INTERNATIONAL | 2005年 / 95卷 / 03期
关键词：
D O I：
10.1111/j.1464-410X.2005.05280.x
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：275 / 278
页数：4
相关论文
共 50 条
  • [21] Oncological and peri-surgical outcomes of radical prostatectomy for non-metastatic prostate cancer with prostate-specific antigen level of 50 ng/ml or greater
    Makino, Katsuhiro
    Nakagawa, Tohru
    Ito, Eisaku
    Kasahara, Ichiro
    Murata, Takashi
    Fujimura, Tetsuya
    Fukuhara, Hiroshi
    Homma, Yukio
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2018, 48 (05) : 485 - 490
  • [22] Thiosulfate in urine as a facilitator in the diagnosis of prostate cancer for patients with prostate-specific antigen less or equal 10 ng/mL
    Chwatko, Grazyna
    Forma, Ewa
    Wilkosz, Jacek
    Glowacki, Rafal
    Jozwiak, Pawel
    Rozanski, Waldemar
    Brys, Magdalena
    Krzeslak, Anna
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2013, 51 (09) : 1825 - 1831
  • [23] Clinical features of patients who present with metastatic prostate carcinoma and serum prostate-specific antigen (PSA) levels <10 ng/mL -: The "PSA negative" patients
    Birtle, AJ
    Freeman, A
    Masters, JRW
    Payne, HA
    Harland, SJ
    [J]. CANCER, 2003, 98 (11) : 2362 - 2367
  • [24] Is targeted biopsy really needed when performing systematic prostate biopsy to raise the detection rate for prostate cancer in patients with prostate-specific antigen ≤10 ng/mL?
    Park, Jee Soo
    Koo, Kyo Chul
    Chung, Byung Ha
    Lee, Kwang Suk
    [J]. MEDICINE, 2019, 98 (51)
  • [25] Clinicopathologic Features of Patients with Serum Prostate-Specific Antigen Levels > 1000 ng/mL
    Horwath, Michael
    Oprea-Ilies, Gabriela
    Osunkoya, Adeboye
    [J]. LABORATORY INVESTIGATION, 2024, 104 (03) : S962 - S963
  • [26] INFLUENCE OF PROSTATE CANCER TUMOUR STAGE AND GRADE ON SERUM PROSTATE-SPECIFIC ANTIGEN IN PATIENTS AFTER RADICAL PROSTATECTOMY
    Smiltens, I
    Romula, I
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (06) : 535 - 535
  • [27] A high serum dehydroepiandrosterone concentration is a predictor of candidates for active surveillance in men with serum prostate-specific antigen < 10 ng/mL
    Miyoshi, Yasuhide
    Kawahara, Takashi
    Uemura, Hiroji
    [J]. BMC CANCER, 2022, 22 (01)
  • [28] Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of ≤10 ng/mL and biopsy Gleason score of ≤6, and their influence on PSA progression-free survival after radical prostatectomy
    Weckermann, D
    Goppelt, M
    Dorn, R
    Wawroschek, F
    Harzmann, R
    [J]. BJU INTERNATIONAL, 2006, 97 (06) : 1173 - 1178
  • [29] Nomogram for Prediction of Prostate Cancer with Serum Prostate Specific Antigen Less than 10 ng/mL
    Ahn, Jae Hyun
    Lee, Jeong Zoo
    Chung, Moon Kee
    Ha, Hong Koo
    [J]. JOURNAL OF KOREAN MEDICAL SCIENCE, 2014, 29 (03) : 338 - 342
  • [30] Diagnostic performance of F-18 fluciclovine PET/CT in post-radical prostatectomy prostate cancer patients with rising prostate-specific antigen level ≤0.5 ng/mL
    Teyateeti, Ajalaya
    Khan, Bilal
    Teyateeti, Achiraya
    Chen, Bo
    Bridhikitti, Jidapa
    Pan, Tinsu
    Peng, Wei
    Macapinlac, Homer A.
    Lu, Yang
    [J]. NUCLEAR MEDICINE COMMUNICATIONS, 2020, 41 (09) : 906 - 915
12345